CAS 2414269-68-2

Lj-1-60

CAS: 2414269-68-2

Lj-1-60 is a specific treatment for cancer. It activates the matrix metalloproteinases, which are enzymes that degrade extracellular matrix proteins in cancerous tissues. Lj-1-60 also has an inhibitory effect on growth factor activity, which may contribute to the reduction of tumor size and weight. Lj-1-60 inhibits DNA replication and induces apoptosis in human colon carcinoma cells by activating caspase 3/7. This drug also has an inhibitory effect on angiogenesis, as shown by staining with anti-CD34 antibodies and quantification of microvessel density in tissues from xenograft tumors.

Formel: C₁₇H₁₅BrO₄

Reinheit: Min. 95%

Molekulargewicht: 363.2 g/mol

Ref: 3D-PWD26968